Science | Jotup

Poxel Announces Presentation of PXL065 Phase 1a Results at the Liver Meeting® 2019

Tuesday, November 12, 2019 - 7:00am

POXEL SA (Euronext: POXEL FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH), today announced the presentation of PXL065 Phase 1a results during a poster presentation session at the Liver Meeting 2019 hosted by the American Association for the Study of Liver Diseases (AASLD).

Key Points:

POXEL SA (Euronext: POXEL FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH), today announced the presentation of PXL065 Phase 1a results during a poster presentation session at the Liver Meeting 2019 hosted by the American Association for the Study of Liver Diseases (AASLD).
In the poster presentation, PXL065 was observed to have a favorable safety, tolerability and PK profile in the Phase 1a trial.
Based on preclinical and clinical results, I am excited about the potential for an improved therapeutic profile for PXL065 compared to pioglitazone.
Based upon preclinical and Phase 1 results to date, Poxel believes that PXL065 may have a better therapeutic profile than pioglitazone for NASH.

MEDATURE: Brand Introduction

Tuesday, November 12, 2019 - 3:33am

MEDATURE, an American brand with strong academia background, develops highly efficacious skincare regimen that guarantee results.

Key Points:

MEDATURE, an American brand with strong academia background, develops highly efficacious skincare regimen that guarantee results.
This is a place where science works in perfect harmony with nature and years of medical research meet the latest skincare innovations.
The scientists behind MEDATUREs product development include world-recognized dermatologists and researchers, who are regularly featured in medical publications.
They apply vast knowledge and experience within the entire spectrum of cosmetic and medical dermatology in testing and proving the efficacy of MEDATUREs product line.

Tags:

Cosmetics, Retail, Science, Other Science, Dermatology

Global Design Contest Awards ULiSSES™ Medical Device Grand Prize

Monday, November 11, 2019 - 9:12pm

ULiSSES, a first-of-its-kind medical device, created by Vascular Perfusion Solutions, Inc. (VPS) has been selected as the Grand Prize winner in the 2019 "Create the Future" Design Contest.

Key Points:

ULiSSES, a first-of-its-kind medical device, created by Vascular Perfusion Solutions, Inc. (VPS) has been selected as the Grand Prize winner in the 2019 "Create the Future" Design Contest.
VPS accepted the grand prize along with a $20,000 cash award in New York City on November 8, 2019.
View the full release here: https://www.businesswire.com/news/home/20191111005641/en/
(L-R) Vascular Perfusion Solutions (VPS) Tom DeBrooke, Leonid Bunegin and Rafael Veraza accept the grand prize in the "Create the Future" Design Contest for their creation of ULiSSES, a first-of-its-kind medical device.
The ULiSSES device can also operate as a bioreactor, for example, to potentially grow new skin for burn victims.

Tags:

Medical devices, Health, Surgery, Research, Science, Biotechnology, Branches of biology, Life sciences, Biology, Biotechnology, Cardiovascular physiology, Perfusion, Respiratory physiology, Underwater diving physiology, Bioreactor

Therapy market is projected to attain a size of $1,083.2 million by 2024, growing from $714.4 million in 2018

Monday, November 11, 2019 - 8:10pm

The rising purchasing power, increasing prevalence lifestyle-associated diseases, and surging consumer adoption of natural products are the major factors driving the growth of the market.

Key Points:

The rising purchasing power, increasing prevalence lifestyle-associated diseases, and surging consumer adoption of natural products are the major factors driving the growth of the market.
There are various equipment and consumables available in the North American aromatherapy market.
Some of the significant equipment offered in the market are nebulizing, evaporative, ultrasonic, and heat diffusers.
Homes and offices, beauty spas, and hospitals and clinics are the various end users in the North American aromatherapy market.

Tags:

Articles, Alternative medicine, Aromatherapy, Fringe science, Herbalism, Pseudoscience, Purchasing, Marketplace, Science

World Focused Ion Beam Market Valued at $820 Million in 2019 is Projected to Reach $1.185 Billion by 2024 - ResearchAndMarkets.com

Monday, November 11, 2019 - 6:59pm

The focused ion beam market is projected to grow from USD 820 million in 2019 to USD 1,185 million by 2024; it is expected to grow at a CAGR of 7.6% from 2019 to 2024.

Key Points:

The focused ion beam market is projected to grow from USD 820 million in 2019 to USD 1,185 million by 2024; it is expected to grow at a CAGR of 7.6% from 2019 to 2024.
Among ion sources, the Ga+ liquid metal segment is projected to lead the focused ion beam market from 2019 to 2024.
Among applications, the failure analysis segment of the focused ion beam market is projected to grow at the highest CAGR from 2019 to 2024.
Among verticals, the electronics & semiconductor segment accounted for the largest share of the focused ion beam market in 2019.

Tags:

Other Science, Science, Physical sciences, Semiconductor device fabrication, Thin film deposition, Natural sciences, Chemistry, Ion beam, Focused ion beam, Lithium-ion battery, Compound annual growth rate, Gallium

Global Clinical Study Sponsors and Clinical Research Organizations Gather for the “Era of Life Science Transformation” at Medidata NEXT NYC 2019

Monday, November 11, 2019 - 5:00pm

Medidata NEXT NYC , the premier conference on the digital transformation of life sciences, is set for November 12-13 at Spring Studios in New York City.

Key Points:

Medidata NEXT NYC , the premier conference on the digital transformation of life sciences, is set for November 12-13 at Spring Studios in New York City.
Medidata customers and partners, including senior executives and experts from global study sponsors and clinical research organizations (CROs), will lead more than 80 percent of these sessions.
Medidata NEXT NYC will also host a one-day hackathon, Real Patients, Virtual Trials , to inspire innovation around patient-centric clinical trials.
These professionals gather for networking and learning across six Medidata NEXT conferences in Basel, London, New York, Seoul, Shanghai and Tokyo.

Oragenics, Inc. SVP of Discovery Research, Martin Handfield, Ph.D. to Be Featured Speaker at the International Conference on Microbial Research and Applications

Monday, November 11, 2019 - 3:22pm

The International Conference on Microbial Research and Applications will be held November 13-14, 2019 at the Radisson Hotel, Downton-Inner Harbor in Baltimore, Md.

Key Points:

The International Conference on Microbial Research and Applications will be held November 13-14, 2019 at the Radisson Hotel, Downton-Inner Harbor in Baltimore, Md.
Dr. Handfields talk will be titled, Lantibiotics: a large untapped pipeline of attractive scaffolds for the development of novel antibiotics.
Those interested in attending the talk may register for the conference via its website, https://unitedscientificgroup.com/conferences/microbiology-research/ .
Lantibiotics are a class of antibiotic compounds with novel mechanism of action, prized for their ability to overcome antibiotic-resistant infections.

Tags:

Science, Other Science, Biotechnology, Research, Pharmaceutical, General Health, Health, Infectious diseases, Articles, Health, Lantibiotics, Branches of biology, Antibiotic, Antimicrobial resistance

Inamori Foundation Presents 2019 Kyoto Prizes

Monday, November 11, 2019 - 3:04pm

In an elaborate ceremony before approximately 1,500 guests here yesterday, the Inamori Foundation presented its 35th Annual Kyoto Prizes, Japans highest private awards for global achievement, in the categories of Advanced Technology, Basic Sciences, and Arts and Philosophy.

Key Points:

In an elaborate ceremony before approximately 1,500 guests here yesterday, the Inamori Foundation presented its 35th Annual Kyoto Prizes, Japans highest private awards for global achievement, in the categories of Advanced Technology, Basic Sciences, and Arts and Philosophy.
View the full release here: https://www.businesswire.com/news/home/20191111005411/en/
Receiving the Inamori Foundation's Kyoto Prize on Sunday, Nov. 10, 2019 are (from left) Dr. Ching Tang, Dr. James Gunn, and Ms. Ariane Mnouchkine.
(Photo courtesy of Inamori Foundation)
In Advanced Technology, the 2019 Kyoto Prize was presented to chemist Ching W. Tang, Ph.D., Professor Emeritus, University of Rochester, and IAS Bank of East Asia Professor at The Hong Kong University of Science and Technology.
The Kyoto Prize is an international award bestowed by the non-profit Inamori Foundation to honor those who have contributed significantly to the scientific, cultural, and spiritual betterment of humankind.

Chemical & Engineering News Names Frontier Medicines One of its 10 Chemistry Start-Ups to Watch

Monday, November 11, 2019 - 4:05pm

SOUTH SAN FRANCISCO, Nov. 11, 2019 /PRNewswire/ -- Frontier Medicines announced today that Chemical & Engineering News (C&EN), published by the American Chemical Society (ACS ), selected the company for its annual list of 10 Chemistry Start-ups to Watch.

Key Points:

SOUTH SAN FRANCISCO, Nov. 11, 2019 /PRNewswire/ -- Frontier Medicines announced today that Chemical & Engineering News (C&EN), published by the American Chemical Society (ACS ), selected the company for its annual list of 10 Chemistry Start-ups to Watch.
"All of us at Frontier Medicines are thrilled to be recognized by Chemical & Engineering News on their list of 10 chemistry start-ups to watch," said Chris Varma, Ph.D., co-founder and CEO of Frontier Medicines.
Our entire team would like to thank Chemical & Engineering News for including Frontier Medicines in this amazing group of start-ups and entrepreneurs."
A leader in chemoproteomics, Frontier Medicines' proprietary platform integrates advanced computational approaches and machine learning to develop medicines against previously inaccessible disease-causing proteins.

Tags:

American Chemical Society, Green chemistry, Chemist, Science, Knowledge

Battelle Celebrates Veterans with Donations to Honor Flight Columbus, National Veterans Memorial and Museum

Monday, November 11, 2019 - 2:08pm

Battelles donation of $70,000 will fully support an Honor Flight Columbus trip to Washington D.C. next May in which about 100 veterans and 50 volunteers will fill a chartered Boeing 737-700.

Key Points:

Battelles donation of $70,000 will fully support an Honor Flight Columbus trip to Washington D.C. next May in which about 100 veterans and 50 volunteers will fill a chartered Boeing 737-700.
In addition, Battelle has made a supplemental gift of $50,000 to the National Veterans Memorial and Museum in Columbus to advance programming for visitors to the museum.
Last year, Battelle donated $500,000 to establish the Battelle Memorial Veteran Education Youth Program to help the new veterans museum develop interactive exhibits and support a paid summer fellowship program for college students.
This additional contribution is our acknowledgement of the outstanding programming and mission of the National Veterans Memorial and Museum, said Von Thaer.